Mar 11, 09:10
Mar 11, 09:07
AnnouncementsWockhardt fixes record date for second interim dividend
AnnouncementsWockhardt: Outcome of board meeting
AnnouncementsWockhardt declares 100% second interim dividend
AnnouncementsWockhardt: Updates on credit rating by CARE
|Company Name||Last Price||%
|Dr Reddys Labs||2676.50||-0.47||2939.80||1786.50||45,529.64|
|Sep' 13||Jun' 13||Mar' 13||Dec' 12|
Wockhardt is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 4,844.42 crore.The company has reported a consolidated sales of Rs 1,236.35 crore and a Net Profit of Rs 305.28 crore for the quarter ended Dec 2013.
The company management includes Habil Khorakiwala - Chairman & Group CEO, Murtaza Khorakiwala - Managing Director, Huzaifa Khorakiwala - Executive Director, R A Shah - Director, Aman Mehta - Director, Shekhar Datta - Director, D S Brar - Director, Sanjaya Baru - Director.
It is listed on the BSE with a BSE Code of 532300 and the NSE with an NSE Code of WOCKPHARMA.
Its Registered office is at Wockhardt Towers, Bandra-Kurla Complex,,Bandra (East) Mumbai,Maharashtra - 400051.
Their Registrars are Link Intime India Pvt. Ltd.